Quantitative Investment Management, LLC Vertex Pharmaceuticals Inc Transaction History

Quantitative Investment Management, LLC

$1.02 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $2.55 Million - $3.15 Million	-6,488 Reduced 31.2%	14,306 $6.71 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $13.4 Million - $14.7 Million	-32,900 Reduced 61.27%	20,794 $8.69 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $17.3 Million - $20.7 Million	50,515 Added 1589.02%	53,694 $21.8 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $2.02 Million - $2.17 Million	-5,974 Reduced 65.27%	3,179 $1.11 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $597,398 - $668,629	-1,900 Reduced 17.19%	9,153 $3.22 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $3.13 Million - $3.57 Million	11,053 New	11,053 $3.48 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $4.79 Million - $5.64 Million	-21,622 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $3.83 Million - $4.83 Million	21,622 New	21,622 $4.75 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $4.83 Million - $5.72 Million	-18,876 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $3.04 Million - $3.98 Million	13,461 Added 248.59%	18,876 $5.48 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $35.4 Million - $43.9 Million	-177,060 Reduced 97.03%	5,415 $1.29 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $26.1 Million - $35.1 Million	156,614 Added 605.6%	182,475 $40 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $485,059 - $545,928	-2,918 Reduced 10.14%	25,861 $4.38 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $967,742 - $1.12 Million	5,879 Added 25.67%	28,779 $5.28 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $3.75 Million - $4.46 Million	22,900 New	22,900 $4.21 Million
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $3.93 Million - $4.98 Million	-25,900 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $2.28 Million - $2.62 Million	13,600 Added 110.57%	25,900 $4.99 Million
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $218,580 - $254,940	1,500 Added 13.89%	12,300 $2.09 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $16.9 Million - $19.7 Million	-111,500 Reduced 91.17%	10,800 $1.76 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $16.8 Million - $19 Million	122,300	122,300 $18.3 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.

Account